|
Report ID
|
16553 |
|
Drug Identification Number
|
02230578 |
|
Brand name
|
TWINRIX |
|
Common or Proper name
|
Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine |
|
Company Name
|
GLAXOSMITHKLINE INC |
|
Market Status
|
MARKETED |
|
Active Ingredient(s)
|
HEPATITIS A VACCINE, INACTIVATED
HEPATITIS B SURFACE ANTIGEN |
|
Strength(s)
|
720UNIT
20MCG |
|
Dosage form(s)
|
SUSPENSION |
|
Route of administration
|
INTRAMUSCULAR |
|
Packaging size
|
1's |
|
ATC code
|
J07BC |
|
ATC description
|
VIRAL VACCINES |
|
Reason for shortage
|
Delay in shipping of the drug. |
|
Anticipated start date
|
|
|
Actual start date
|
2017-07-18 |
|
Estimated end date
|
2017-12-07 |
|
Actual end date
|
2017-12-04 |
|
Shortage status
|
Resolved |
|
Updated date
|
2017-12-06 |
|
Company comments
|
Supply released July 10, 2017, August 9, 2017, October 3, 2017, and October 20, 2017 with limited quantity. Supply disruptions may be seen in the private market. Product under allocation. |
|
Health Canada comments
|
|
|
Tier 3 Status
|
No |
| Company contact information |
1-800-387-7374 |
